Alternus Energy Group plc ("Alternus") (OSE: ALT) today announced the establishment of its development business, Altnua, which aims to become one of the leading specialist renewable asset developers in...
Alternus Energy Group Plc (" Alternus " or the " Company ") (OSE: ALT) and Clean Earth Acquisitions Corp. (NASDAQ: CLIN) (“ Clean Earth ”), a climate technology and energy transition-focused special...
Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ announced today that lenzilumab is now...
Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, announces that its Clinical Services (CS) business has expanded its exclusive ’on-demand’ supply service...